Key result
11C-meta-hydroxyephedrine (HED) is a PET tracer used to assess the cardiac sympathetic nervous system in heart failure, myocardial infarction, and arrhythmias, as well as sympathetic tumors.
This review summarizes the mechanism, radiosynthesis, and clinical applications of 11C-meta-hydroxyephedrine (HED) PET imaging for assessing the cardiac sympathetic nervous system in various cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
May aid HED PET sympathetic imaging in HF and arrhythmias; leaves open prospective outcome validation.
Dysfunction of the sympathetic nervous system underlies many cardiac diseases and can be assessed by molecular imaging using SPECT tracers as I-metaiodobenzylguanidine (I-MIBG). The norepinephrine analog C-meta-hydroxyephedrine (HED) has been used with PET to map the regional distribution of cardiac sympathetic neurons. Hydroxyephedrine is rapidly transported into sympathetic neurons by the norepinephrine transporter and stored in vesicles. This review describes the mechanism of action, radiosynthesis, and application of HED in the assessment of the cardiac sympathetic nervous system in heart failure, myocardial infarction, and arrhythmias. Noncardiac applications of HED in the clinical setting of sympathetic nervous system tumors and other emerging research applications are described.
No takes yet. Share an insight, caveat, or question.
Boschi et al. (2014) conducted a review in Cardiac diseases (heart failure, myocardial infarction, arrhythmias). 11C-meta-hydroxyephedrine (HED) was evaluated. 11C-meta-hydroxyephedrine (HED) is a PET tracer used to assess the cardiac sympathetic nervous system in heart failure, myocardial infarction, and arrhythmias, as well as sympathetic tumors.
Synapse has enriched 10 related papers. Consider them for comparative context: